Skip to main content
915 TLDR
Health
1 read

Texas Tech Health El Paso Secures Over $1 Million for Cancer Treatment Technology

KVIA••Gabrielle Lopez
Medical stethoscope representing healthcare news

Want the full story?

Read the complete article at KVIA

Read Original

AI Summary

Texas Tech Health El Paso has been awarded $1.031 million in federal funding for the future Fox Cancer Center, aimed at enhancing cancer treatment in the region. U.S. Representative Veronica Escobar presented the check, emphasizing that the funding will support a linear accelerator (LINAC) that precisely targets tumors while minimizing damage to surrounding healthy tissue. This initiative is crucial for improving accessibility to cancer care for local residents, alleviating the financial burden often associated with traveling for treatment. The funding was secured through a competitive application process, highlighting the importance of community-focused healthcare advancements.

Key Details: • Funding amount: $1.031 million • Presented by U.S. Rep. Veronica Escobar • Technology: Linear accelerator (LINAC) for cancer treatment • Goal: Improve accessibility to cancer care for El Paso residents

healthcare el-paso cancer texas-tech federal-funding

People & Organizations

Texas Tech Health El PasoFox Cancer CenterVeronica Escobar

Related Articles

KTSM•Jun 19

Massive Pet Food Recall Affects Over 400,000 Pounds Across Multiple States

A significant recall of over 400,000 pounds of pet food has been announced, impacting several states, including Texas. The affected products were manufactured between July 17, 2025, and December 23, 2025, with an additional batch produced on March 31, 2026. This recall is crucial for pet owners to ensure the safety and health of their animals, as consuming contaminated food can lead to serious health issues. Pet owners should check their supplies and dispose of any recalled products immediately to prevent harm to their pets.

Health
1 min read
KTSM•Jun 19

Understanding 'Ghost Fat': A New Phenomenon from Weight-Loss Injections

Individuals who have used injectable weight-loss medications are reporting a phenomenon known as 'ghost fat.' This term refers to the lingering behaviors and habits that persist even after significant weight loss, as users may subconsciously continue actions associated with their previous larger size. This psychological effect can impact their ongoing weight management and self-image. Understanding 'ghost fat' is crucial for both users and healthcare providers to address potential challenges in maintaining a healthy lifestyle post-treatment.

Health
1 min read
KTSM•Jun 19

Understanding 'Ghost Fat': A New Phenomenon from Weight-Loss Injections

Recent findings reveal that individuals using injectable weight-loss medications may experience a phenomenon known as 'ghost fat.' This term refers to the lingering psychological effects and behaviors that persist even after significant weight loss. As people shed pounds, they might unconsciously maintain habits associated with their previous larger size, impacting their mental health and body image. This issue highlights the importance of addressing both physical and psychological aspects of weight loss treatments. Awareness of 'ghost fat' can help those affected navigate their post-weight-loss journey more effectively.

Health
1 min read
KTSM•Jun 19

Uncertainty Surrounds FDA Decision on Moderna's mRNA Flu Vaccine for Seniors

An FDA advisory panel has recommended the use of Moderna's mRNA flu vaccine for older adults, but the absence of a permanent vaccine chief and commissioner raises questions about the decision-making process. This recommendation is significant as it could enhance flu prevention among vulnerable populations, particularly seniors who are at higher risk for severe illness. The timeline for a final decision remains unclear, leaving many in the healthcare community and potential vaccine recipients in anticipation of the next steps.

Health
1 min read